Evidence map›Paper›PMID 39689145›Full record

ArticlePloS one2024

Enhanced detection of distinct honeycomb-structured neuronal SMARCC2 cytobodies in Parkinson's Disease via Cyclic Heat-Induced Epitope Retrieval (CHIER).

Amber Carmichael-Lowe, Brionne Fleming, Kreesan Reddy, James Wiseman, Eden Paige Yin, Clinton P Turner, Richard L M Faull, Maurice A Curtis, Mike Dragunow, Birger Victor Dieriks

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Amber Carmichael-LoweDepartment of Anatomy and Medical Imaging, University of Auckland, Auckland, New Zealand.
Brionne FlemingDepartment of Anatomy and Medical Imaging, University of Auckland, Auckland, New Zealand.
Kreesan ReddyDepartment of Anatomy and Medical Imaging, University of Auckland, Auckland, New Zealand.ORCID 0000-0001-7892-8579
James WisemanDepartment of Anatomy and Medical Imaging, University of Auckland, Auckland, New Zealand.
Eden Paige YinDepartment of Anatomy and Medical Imaging, University of Auckland, Auckland, New Zealand.ORCID 0009-0001-4816-6531
Clinton P TurnerCentre for Brain Research, University of Auckland, Auckland, New Zealand.
Richard L M FaullDepartment of Anatomy and Medical Imaging, University of Auckland, Auckland, New Zealand.
Maurice A CurtisDepartment of Anatomy and Medical Imaging, University of Auckland, Auckland, New Zealand.
Mike DragunowCentre for Brain Research, University of Auckland, Auckland, New Zealand.
Birger Victor DieriksDepartment of Anatomy and Medical Imaging, University of Auckland, Auckland, New Zealand.ORCID 0000-0002-9392-3327

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antigen retrieval is crucial for immunohistochemistry, particularly in formalin-fixed paraffin-embedded brain tissue, where fixation causes extensive crosslinking that masks epitopes. Heat Induced Epitope Retrieval (HIER) reverses these crosslinks, improving access to nuclear and aggregated proteins. We introduce Cyclic Heat-Induced Epitope Retrieval (CHIER), an advanced technique that builds on HIER by incorporating repeated cycles of heating and cooling. CHIER optimises antigen retrieval and significantly improves detection. CHIER is particularly effective for detecting chromatin-binding proteins, such as SMARCC2, which are difficult to label using conventional IHC methods. Using CHIER on formalin-fixed paraffin-embedded human brain sections, we achieved robust detection of SMARCC2 in both the nucleus and cytoplasm. CHIER also enhanced the visualisation of large SMARCC2+ cytoplasmic bodies, termed cytobodies, which are increased in Parkinson's Disease (PD). Our findings suggest that SMARCC2 may translocate from the nucleus to the cytoplasm in PD, potentially implicating SMARCC2 aggregation in the disease's pathology. Furthermore, CHIER does not negatively impact the antigenicity of other antibodies, supporting its use for multiplex fluorescent immunohistochemistry and super-resolution imaging. These results highlight CHIER's potential for improving the detection of chromatin-binding and aggregated proteins in neurodegenerative disease research, offering new insights into SMARCC2's role in Parkinson's Disease.

Indexed as

EpitopesHot TemperatureParkinson DiseaseBrainCell NucleusCytoplasmHumansImmunohistochemistryNeuronsEpitopes

Identifiers

PMID39689145
PMCPMC11651576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.